Clinicians' Knowledge, Attitudes, and Practices Regarding the Management of Functional Gastrointestinal Disorders With Neuromodulators and Psychological Treatment.

Autor: Shin SY; Chung-Ang University College of Medicine, Department of Internal Medicine, Seoul, Korea., Lee JY; Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea., Jung SW; Catholic Kwandong University International St. Mary's Hospital, Incheon, Korea., Jang SH; Department of Psychiatry, Wonkwang University School of Medicine, Iksan, Jeonbuk-do, Korea., Ryu HS; Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Jeonbuk-do, Korea., Lee A; Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Gyeonggi-do, Korea., Park GT; Korean Physicians' Association., Chang W; The Korean Society of Digestive Endoscopy., Kim M; Department of Applied Statistics, Chung-Ang University, Seoul, Korea., Hwang BS; Department of Applied Statistics, Chung-Ang University, Seoul, Korea., Kim YS; Digestive Disease Research Institute, Wonkwang University School of Medicine, Iksan, Jeonbuk-do, Korea., Kwon JG; Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.
Jazyk: angličtina
Zdroj: Journal of neurogastroenterology and motility [J Neurogastroenterol Motil] 2024 Oct 30; Vol. 30 (4), pp. 480-490.
DOI: 10.5056/jnm23161
Abstrakt: Background/aims: Little is known about the practical clinical application of neuromodulators and psychiatric treatments in patients with functional gastrointestinal disorders (FGIDs). We investigate the knowledge, attitudes, and practices of Korean clinicians regarding the use of neuromodulators and psychiatric treatments for FGIDs.
Methods: This prospective, online, cross-sectional study was conducted between May and August 2022. A questionnaire regarding the knowledge, attitude, and practice of neuromodulators and psychiatric treatments for FGIDs was developed and administered to primary care clinicians and gastroenterologists in university hospitals in Korea.
Results: Overall, 451 clinicians from primary (n = 179, 39.7%), secondary (n = 113, 25.1%), and tertiary (n = 159, 35.3%) hospitals participated in the survey. Most of them considered that neuromodulators (98.7%) and psychiatric treatment (86.5%) were required for patients with FGIDs. However, approximately one-third of them did not prescribe neuromodulators, mainly due to unfamiliarity with the drugs, and only one-quarter considered psychiatric referral. Compared to gastroenterologists at university hospitals, primary care clinicians' prescriptions had a lower rate (87.2% vs 64.2%, P < 0.001) and shorter duration of neuromodulator. The psychiatric referral rate was lower for primary care clinicians than for gastroenterologists at university hospitals (19.0% vs 34.2%, P < 0.001).
Conclusions: Knowledge, attitude, and practice levels regarding neuromodulators and psychiatric treatment among clinicians are inhomogeneous, and a knowledge gap exists between primary care clinicians and gastroenterologists at university hospitals. Encouraging ongoing education for Korean clinicians regarding the appropriate use of neuromodulators and psychiatric treatments in patients with FGIDs is suggested.
Databáze: MEDLINE
Externí odkaz: